Repository logo
 
Publication

Loss of mothers against decapentaplegic homolog 4 (SMAD4) expression and its correlation with clinicopathological parameters in pancreatic carcinoma

2021Journal article Open access
Simple item page
dc.contributor.authorVareda, Catarina
dc.contributor.authorTeixeira, P.F.
dc.contributor.authorMartins, D.R.
dc.contributor.authorValado, A.M.
dc.contributor.authorMendes, F.J.
dc.date.accessioned2022-08-02T12:55:23Z
dc.date.available2022-08-02T12:55:23Z
dc.date.issued2021
dc.description.abstractAbstract: Pancreatic cancer (PC) has an important role in the clinical and research area representing one of the lowest five-year rates as well as a global mortality rate of 4.8% due to its late and poor diagnosis. Therapeutic strategies have also an unsatisfactory response. Even after surgery, the recurrence or appearance of metastasis are frequent, leading to a poor overall survival. The PC has been related with several mutations, including K-RAS; P16; TP53; HER2. Besides, it is also associated with the deleted in pancreatic cancer locus 4 (DPC4), also known as the suppressor mothers against decapentaplegic homolog 4 (SMAD4) which is present in nearly 50% of the diagnosed patients with PC. Preceding studies proved that SMAD4 loss expression plays an important role in tumorigenesis and in the promotion of pancreatic carcinoma´s growth. Therefore, it is highly relevant in late stages suggesting that SMAD4 may be a molecular biomarker in prognostic results. The main goal of this review is to highlight the foregoing findings focused on SMAD4 deletion and its influence in clinicopathological parameters in pancreatic carcinoma by referring some of the investigations and clinical trials made in this field. Furthermore, it is also required to contemplate some of the therapeutical strategies and the influence of SMAD4 in future therapiespt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationVAREDA, C. [et al.] (2021) - Loss of mothers against decapentaplegic homolog 4 (SMAD4) expression and its correlation with clinicopathological parameters in pancreatic carcinoma. HIGEIA: Revista Científica da Escola Superior de Saúde Dr. Lopes Dias. ISSN 2184-5565. Ano III, vol. 6, n.º 2, p.65-71.pt_PT
dc.identifier.issn2184-5565
dc.identifier.urihttp://hdl.handle.net/10400.11/8069
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherIPCB. ESALDpt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectPancreatic cancerpt_PT
dc.subjectSMAD4pt_PT
dc.subjectTGF-βpt_PT
dc.titleLoss of mothers against decapentaplegic homolog 4 (SMAD4) expression and its correlation with clinicopathological parameters in pancreatic carcinomapt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceCastelo Brancopt_PT
oaire.citation.endPage71pt_PT
oaire.citation.issueAno IIIpt_PT
oaire.citation.startPage65pt_PT
oaire.citation.titleHIGEIA: Revista Científica da Escola Superior de Saúde Dr. Lopes Diaspt_PT
oaire.citation.volumeVI, 2pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
07_Loss of mothers against decapentaplegic homolog 4 SMAD4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.pdf
Size:
177.28 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.02 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

HIGEIA - Revista Científica da Escola Superior de Saúde Dr. Lopes Dias